GCG and type 2 diabetes mellitus: In a T2DM murine model, ezetimibe therapy was proven to raise the number of pancreatic β-cells as well as enhance the effect of glucagon-like peptide-1, an incretin hormone that promotes the release of insulin, shedding light on some benefits of ezetimibe [19].